BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16685408)

  • 1. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB.
    Gwak J; Park S; Cho M; Song T; Cha SH; Kim DE; Jeon YJ; Shin JG; Oh S
    Int J Mol Med; 2006 Jun; 17(6):1005-10. PubMed ID: 16685408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
    Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
    FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
    Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
    FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
    Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RelA suppresses the Wnt/beta-catenin pathway without exerting trans-acting transcriptional ability.
    Masui O; Ueda Y; Tsumura A; Koyanagi M; Hijikata M; Shimotohno K
    Int J Mol Med; 2002 May; 9(5):489-93. PubMed ID: 11956654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
    Gehrke I; Gandhirajan RK; Kreuzer KA
    Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
    Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
    Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
    Dillard AC; Lane MA
    Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells.
    Railo A; Nagy II; Kilpeläinen P; Vainio S
    Exp Cell Res; 2008 Aug; 314(13):2389-99. PubMed ID: 18572162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
    Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
    Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling.
    Bi X; Zhao Y; Fang W; Yang W
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1074-8. PubMed ID: 19413587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.
    Bos CL; Diks SH; Hardwick JC; Walburg KV; Peppelenbosch MP; Richel DJ
    Carcinogenesis; 2006 Dec; 27(12):2371-82. PubMed ID: 16728434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.